期刊文献+

高效液相色谱法测定人体血浆中鲁拉西酮的含量 被引量:4

HPLC determination of lurasidone in human plasma
原文传递
导出
摘要 目的:建立高效液相色谱法测定人体血浆中鲁拉西酮的含量。方法:色谱柱为美国Diamonsil(250 mm×4.6 mm,5μm)C18反相柱;流动相为乙腈-甲醇-缓冲液(35∶15∶50),流速为1.2 mL.min-1;检测波长256 nm。结果:鲁拉西酮血浆浓度在0.018~2.304μg.mL-1范围内线性关系良好,平均相对回收率为97.08%,平均日间精密度为4.58%。结论:本方法具有快速、简便、灵敏度高、重复性好等优点,可以用于鲁拉西酮临床研究和不良反应监测。 OBJECTIVE To establish the determination of lurasidone in plasma by HPLC. METHODS Column was Diamonsil C18 (250 mm ×4.6mm,5μm) ; Mobile phase was acetonitrile: MeOH : Buffer (35 : 15 : 50), the flow rate was l. 2 mL. min^- 1 UV wavelength was 256 nrru RESULTS Within a concentration range of 0. 018 - 2. 304μg. mL^-1 , the standard curve of lurasi- done had a good linearity. The average relative recovery was 97. 08%, the average daytime precision was 4. 58 %. CONCLUSION It appears to be a rapid, convenient, sensitive and reproducible method for clinical research and adverse reaction monitor of lurasidone.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第4期262-264,共3页 Chinese Journal of Hospital Pharmacy
基金 河南省2010年科技发展计划项目(编号:102102310153)
关键词 高效液相色谱法 鲁拉西酮 血浆 含量测定 HPLC lurasidone plasma determination
  • 相关文献

参考文献6

  • 1Meyer J M, Loebelad,Schweizer E. Lurasidone: a new drug in development for schizophrenia [J ]. Expert Opin Investig Drugs,2009,18(11): 1715-1726.
  • 2Meltzer HY, Cucchiaro J, Silva R, et al. Lurasidone in the treatment of schizophrenia: a randomized, double-blind,place- bo and olanzapine-controlled study[J]. Am J Psychiatry, 2011, 168 (9) : 957-967.
  • 3Citrome L. Lurasidone for schizophrenia: a review of the effi- cacy and safety profile for this newly approved second-genera- tion antipsychotic[J]. Int J Clin Pract,2011,65(2) : 189-210.
  • 4Ishiyama T,Tokuda K, Ishibashi T. Lurasidone( SM13496), a novel atypical antipsychotic drug, reverses MK801 induced im pairment of learning and memory in the rat passive-avoidance test[J]. Eur J Pharmacol,2007,572(2/3) : 160-170.
  • 5Koo T S, Kim S J, Lee J, et al. Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high perform- ance liquid chromatography with tandem mass spectrometry [J]. Biomed Chromatogr, 2011,9 : 1625.
  • 6Lurasidone [EB/OL]. [2011-01-17]. http: //www. Access data fda gov/drugsatfda_docs/label/2010/200603s001 lbl. pdf.

同被引文献15

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部